Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT00847834
Eligibility Criteria:
Inclusion criteria:
* Systolic blood pressure \< 180 mmHg
* 90 mmHg ≤ Diastolic blood pressure \< 110 mmHg
Exclusion criteria:
* Pregnancy or lactation. Women of child bearing potential (not post-menopausal) should be using a reliable contraceptive method
* Known or suspected secondary hypertension (e.g., coarctation of aorta, renovascular stenosis, etc.)
* Presence of clinically significant ventricular or supraventricular arrhythmias, or second or third degree atrioventricular block, or sick sinus syndrome
* ALAT\[SGPT\]\>2 times of upper limit，
* ASAT\[SGOT\]\>2 times of upper limit
* Patients with known renal disease
* Serum potassium \> normal upper limit
* Uncontroled BD（FBG\>10mmol/L or PBG\>12.22mmol/L)
* Patients treated with tricyclic antidepressants
* Clinical hematological disease.
* Patients with a history of irbesartan, or hydrochlorothiazide sensitivity defined as irbesartan, or hydrochlorothiazide discontinuation due to medically significant adverse effects.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00847834
Study Brief:
Protocol Section:
NCT00847834